Skip to main content
Top
Published in: Inflammation 4/2013

01-08-2013

IL-17A/F Modulates Fibrocyte Functions in Cooperation with CD40-Mediated Signaling

Authors: Hisako Hayashi, Akiko Kawakita, Shintaro Okazaki, Motoko Yasutomi, Hiroki Murai, Yusei Ohshima

Published in: Inflammation | Issue 4/2013

Login to get access

Abstract

T helper 17 (Th17) cells that produce interleukin (IL)-17A and IL-17F have been found to participate in the development of bronchial asthma and bleomycin-induced pulmonary fibrosis. However, whether they play a causative role in the airway remodeling observed in these respiratory diseases remains unclear. Because fibrocytes are involved in tissue repair and fibrosis and are presumably precursors of lung fibroblasts and myofibroblasts, we examined the effects of IL-17A/F on fibrocyte functions. Both IL-17A and IL-17F enhanced fibrocytes’ α-smooth muscle actin expression. Priming fibrocytes with IL-17A enhanced their CD40-mediated IL-6 production, whereas IL-17F-priming increased the CD40-mediated mRNA expression of collagen I, vascular endothelial growth factor, and angiogenin. CD4+ T cells co-cultured with fibrocytes produced IL-17A, which was inhibited by blocking CD40 and CD40 ligand interactions. These findings suggest that cooperative interactions between fibrocytes and Th17 cells play an important role via CD40- and IL-17A/F-mediated signaling for collagen and proangiogenic factor production, which may lead to the extracellular matrix deposition and neovascularization seen in airway remodeling.
Literature
1.
go back to reference Abe, R., S.C. Donnelly, T. Peng, R. Bucala, and C.N. Metz. 2001. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. The Journal of Immunolgy 166: 7556–7562. Abe, R., S.C. Donnelly, T. Peng, R. Bucala, and C.N. Metz. 2001. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. The Journal of Immunolgy 166: 7556–7562.
2.
go back to reference Quan, T.E., S. Cowper, S.P. Wu, L.K. Bockenstedt, and R. Bucala. 2004. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. The International Journal of Biochemistry & Cell Biology 36: 598–606.CrossRef Quan, T.E., S. Cowper, S.P. Wu, L.K. Bockenstedt, and R. Bucala. 2004. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. The International Journal of Biochemistry & Cell Biology 36: 598–606.CrossRef
3.
go back to reference Bellini, A., and S. Mattoli. 2007. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Laboratory Investigation 87: 858–870.PubMedCrossRef Bellini, A., and S. Mattoli. 2007. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Laboratory Investigation 87: 858–870.PubMedCrossRef
4.
go back to reference Gomperts, B.N., and R.M. Strieter. 2007. Fibrocytes in lung disease. Journal of Leukocyte Biology 82: 449–456.PubMedCrossRef Gomperts, B.N., and R.M. Strieter. 2007. Fibrocytes in lung disease. Journal of Leukocyte Biology 82: 449–456.PubMedCrossRef
5.
go back to reference Wang, J., H. Jiao, T.L. Stewart, M.V. Lyons, H.A. Shankowsky, P.G. Scott, and E.E. Tredget. 2007. Accelerated wound healing in leukocyte-specific, protein 1-deficient mouse is associated with increased infiltration of leukocytes and fibrocytes. Journal of Leukocyte Biology 82: 1554–63.PubMed Wang, J., H. Jiao, T.L. Stewart, M.V. Lyons, H.A. Shankowsky, P.G. Scott, and E.E. Tredget. 2007. Accelerated wound healing in leukocyte-specific, protein 1-deficient mouse is associated with increased infiltration of leukocytes and fibrocytes. Journal of Leukocyte Biology 82: 1554–63.PubMed
6.
go back to reference Epperly, M.W., H. Guo, J.E. Gretton, and J.S. Greenberger. 2003. Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. American Journal of Respiratory Cell and Molecular Biology 29: 213–224.PubMedCrossRef Epperly, M.W., H. Guo, J.E. Gretton, and J.S. Greenberger. 2003. Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. American Journal of Respiratory Cell and Molecular Biology 29: 213–224.PubMedCrossRef
7.
go back to reference Dunsmore, S.E., and S.D. Shapiro. 2004. The bone marrow leaves its scar: new concepts in pulmonary fibrosis. The Journal of Clinical Investigation 113: 180–2.PubMed Dunsmore, S.E., and S.D. Shapiro. 2004. The bone marrow leaves its scar: new concepts in pulmonary fibrosis. The Journal of Clinical Investigation 113: 180–2.PubMed
8.
go back to reference Phillips, R.J., M.D. Burdick, K. Hong, M.A. Lutz, L.A. Murray, Y.Y. Xue, J.A. Belperio, M.P. Keane, and R.M. Strieter. 2004. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. The Journal of Clinical Investigation 114: 438–446.PubMed Phillips, R.J., M.D. Burdick, K. Hong, M.A. Lutz, L.A. Murray, Y.Y. Xue, J.A. Belperio, M.P. Keane, and R.M. Strieter. 2004. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. The Journal of Clinical Investigation 114: 438–446.PubMed
9.
go back to reference Ishii, G., T. Sangai, K. Sugiyama, T. Ito, T. Hasebe, Y. Endoh, J. Magae, and A. Ochiai. 2005. In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. Stem Cells 23: 699–706. Ishii, G., T. Sangai, K. Sugiyama, T. Ito, T. Hasebe, Y. Endoh, J. Magae, and A. Ochiai. 2005. In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. Stem Cells 23: 699–706.
10.
go back to reference Yang, L., P.G. Scott, J. Giuffre, H.A. Shankowsky, A. Ghahary, and E.E. Tredget. 2002. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Laboratory Investigation 82: 1183–1192.PubMed Yang, L., P.G. Scott, J. Giuffre, H.A. Shankowsky, A. Ghahary, and E.E. Tredget. 2002. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Laboratory Investigation 82: 1183–1192.PubMed
11.
go back to reference Schmidt, M., G. Sun, M.A. Stacey, L. Mori, and S. Mattoli. 2003. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. The Journal of Immunology 171: 380–389.PubMed Schmidt, M., G. Sun, M.A. Stacey, L. Mori, and S. Mattoli. 2003. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. The Journal of Immunology 171: 380–389.PubMed
12.
go back to reference Mehrad, B., M.D. Burdick, D.A. Zisman, M.P. Keane, J.A. Belperio, and R.M. Strieter. 2007. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochemical and Biophysical Research Communications 353: 104–108.PubMedCrossRef Mehrad, B., M.D. Burdick, D.A. Zisman, M.P. Keane, J.A. Belperio, and R.M. Strieter. 2007. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochemical and Biophysical Research Communications 353: 104–108.PubMedCrossRef
13.
go back to reference Herzog, E.L., and R. Bucala. 2010. Fibrocytes in health and disease. Experimental Hematology 38: 548–556.PubMedCrossRef Herzog, E.L., and R. Bucala. 2010. Fibrocytes in health and disease. Experimental Hematology 38: 548–556.PubMedCrossRef
14.
go back to reference Moeller, A., S.E. Gilpin, K. Ask, G. Cox, D. Cook, J. Gauldie, P.J. Margetts, L. Farkas, J. Dobranowski, C. Boylan, P.M. O'Byrne, R.M. Strieter, and M. Kolb. 2009. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 179: 588–594.PubMedCrossRef Moeller, A., S.E. Gilpin, K. Ask, G. Cox, D. Cook, J. Gauldie, P.J. Margetts, L. Farkas, J. Dobranowski, C. Boylan, P.M. O'Byrne, R.M. Strieter, and M. Kolb. 2009. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 179: 588–594.PubMedCrossRef
15.
go back to reference Wang, C.H., C.D. Huang, H.C. Lin, K.Y. Lee, S.M. Lin, C.Y. Liu, K.H. Huang, Y.S. Ko, K.F. Chung, and H.P. Kuo. 2008. Increased circulating fibrocytes in asthma with chronic airflow obstruction. American Journal of Respiratory and Critical Care Medicine 178: 583–591.PubMedCrossRef Wang, C.H., C.D. Huang, H.C. Lin, K.Y. Lee, S.M. Lin, C.Y. Liu, K.H. Huang, Y.S. Ko, K.F. Chung, and H.P. Kuo. 2008. Increased circulating fibrocytes in asthma with chronic airflow obstruction. American Journal of Respiratory and Critical Care Medicine 178: 583–591.PubMedCrossRef
16.
go back to reference Wick, G., A. Backovic, E. Rabensteiner, N. Plank, C. Schwentner, and R. Sgonc. 2010. The immunology of fibrosis: innate and adaptive responses. Trends in Immunology 31: 110–119.PubMedCrossRef Wick, G., A. Backovic, E. Rabensteiner, N. Plank, C. Schwentner, and R. Sgonc. 2010. The immunology of fibrosis: innate and adaptive responses. Trends in Immunology 31: 110–119.PubMedCrossRef
17.
go back to reference Linden, A. 2006. Interleukin-17 and airway remodelling. Pulmonary Pharmacology & Therapeutics 19: 47–50.CrossRef Linden, A. 2006. Interleukin-17 and airway remodelling. Pulmonary Pharmacology & Therapeutics 19: 47–50.CrossRef
18.
go back to reference Park, S.J., and Y.C. Lee. 2010. Interleukin-17 regulation: an attractive therapeutic approach for asthma. Respiratory Research 11: 78.PubMedCrossRef Park, S.J., and Y.C. Lee. 2010. Interleukin-17 regulation: an attractive therapeutic approach for asthma. Respiratory Research 11: 78.PubMedCrossRef
19.
go back to reference Molet, S., Q. Hamid, F. Davoine, E. Nutku, R. Taha, N. Page, R. Olivenstein, J. Elias, and J. Chakir. 2001. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. The Journal of Allergy and Clinical Immunology 108: 430–438.PubMedCrossRef Molet, S., Q. Hamid, F. Davoine, E. Nutku, R. Taha, N. Page, R. Olivenstein, J. Elias, and J. Chakir. 2001. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. The Journal of Allergy and Clinical Immunology 108: 430–438.PubMedCrossRef
20.
go back to reference Chakir, J., J. Shannon, S. Molet, M. Fukakusa, J. Elias, M. Laviolette, L.P. Boulet, and Q. Hamid. 2003. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. The Journal of Allergy and Clinical Immunology 111: 1293–1298.PubMedCrossRef Chakir, J., J. Shannon, S. Molet, M. Fukakusa, J. Elias, M. Laviolette, L.P. Boulet, and Q. Hamid. 2003. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. The Journal of Allergy and Clinical Immunology 111: 1293–1298.PubMedCrossRef
21.
go back to reference Bullens, D.M., E. Truyen, L. Coteur, E. Dilissen, P.W. Hellings, L.J. Dupont, and J.L. Ceuppens. 2006. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respiratory Research 7: 135.PubMedCrossRef Bullens, D.M., E. Truyen, L. Coteur, E. Dilissen, P.W. Hellings, L.J. Dupont, and J.L. Ceuppens. 2006. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respiratory Research 7: 135.PubMedCrossRef
22.
go back to reference Ouyang, W., J.K. Kolls, and Y. Zheng. 2008. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28: 454–467.PubMedCrossRef Ouyang, W., J.K. Kolls, and Y. Zheng. 2008. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28: 454–467.PubMedCrossRef
23.
24.
go back to reference Wang, Q., H. Li, Y. Yao, D. Xia, and J. Zhou. 2010. The overexpression of heparin-binding epidermal growth factor is responsible for Th17-induced airway remodeling in an experimental asthma model. The Journal of Immunology 185: 834–841.PubMedCrossRef Wang, Q., H. Li, Y. Yao, D. Xia, and J. Zhou. 2010. The overexpression of heparin-binding epidermal growth factor is responsible for Th17-induced airway remodeling in an experimental asthma model. The Journal of Immunology 185: 834–841.PubMedCrossRef
25.
go back to reference Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔC T method. Methods 25: 402–408.PubMedCrossRef Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔC T method. Methods 25: 402–408.PubMedCrossRef
26.
go back to reference Shao, D.D., R. Suresh, V. Vakil, R.H. Gomer, and D. Pilling. 2008. Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. Journal of Leukocyte Biology 83: 1323–1333.PubMedCrossRef Shao, D.D., R. Suresh, V. Vakil, R.H. Gomer, and D. Pilling. 2008. Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. Journal of Leukocyte Biology 83: 1323–1333.PubMedCrossRef
27.
go back to reference Iwakura, Y., H. Ishigame, S. Saijo, and S. Nakae. 2011. Functional specialization of interleukin-17 family members. Immunity 34: 149–162.PubMedCrossRef Iwakura, Y., H. Ishigame, S. Saijo, and S. Nakae. 2011. Functional specialization of interleukin-17 family members. Immunity 34: 149–162.PubMedCrossRef
28.
go back to reference Murray, L.A., Q. Chen, M.S. Kramer, D.P. Hesson, R.L. Argentieri, X. Peng, M. Gulati, R.J. Homer, T. Russell, N. van Rooijen, J.A. Elias, C.M. Hogaboam, and E.L. Herzog. 2011. TGF-beta driven lung fibrosis is macrophage dependent and blocked by serum amyloid P. The International Journal of Biochemistry & Cell Biology 43: 154–162.CrossRef Murray, L.A., Q. Chen, M.S. Kramer, D.P. Hesson, R.L. Argentieri, X. Peng, M. Gulati, R.J. Homer, T. Russell, N. van Rooijen, J.A. Elias, C.M. Hogaboam, and E.L. Herzog. 2011. TGF-beta driven lung fibrosis is macrophage dependent and blocked by serum amyloid P. The International Journal of Biochemistry & Cell Biology 43: 154–162.CrossRef
29.
go back to reference Wilson, M.S., S.K. Madala, T.R. Ramalingam, B.R. Gochuico, I.O. Rosas, A.W. Cheever, and T.A. Wynn. 2010. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. The Journal of Experimental Medicine 207: 535–552.PubMedCrossRef Wilson, M.S., S.K. Madala, T.R. Ramalingam, B.R. Gochuico, I.O. Rosas, A.W. Cheever, and T.A. Wynn. 2010. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. The Journal of Experimental Medicine 207: 535–552.PubMedCrossRef
30.
go back to reference Cua, D.J., and C.M. Tato. 2010. Innate IL-17-producing cells: the sentinels of the immune system. Nature Reviews of Immunology 10: 479–89.CrossRef Cua, D.J., and C.M. Tato. 2010. Innate IL-17-producing cells: the sentinels of the immune system. Nature Reviews of Immunology 10: 479–89.CrossRef
31.
go back to reference Katzman, S.D., E. Gallo, K.K. Hoyer, and A.K. Abbas. 2011. Differential requirements for Th1 and Th17 responses to a systemic self-antigen. The Journal of Immunology 186: 4668–73.PubMedCrossRef Katzman, S.D., E. Gallo, K.K. Hoyer, and A.K. Abbas. 2011. Differential requirements for Th1 and Th17 responses to a systemic self-antigen. The Journal of Immunology 186: 4668–73.PubMedCrossRef
32.
go back to reference Chesney, J., M. Bacher, A. Bender, and R. Bucala. 1997. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proceedings of the National Academy of Sciences of the United States of America 94: 6307–6312.PubMedCrossRef Chesney, J., M. Bacher, A. Bender, and R. Bucala. 1997. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proceedings of the National Academy of Sciences of the United States of America 94: 6307–6312.PubMedCrossRef
33.
go back to reference Saunders, R., S. Siddiqui, D. Kaur, C. Doe, A. Sutcliffe, F. Hollins, P. Bradding, A. Wardlaw, and C.E. Brightling. 2009. Fibrocyte localization to the airway smooth muscle is a feature of asthma. The Journal of Allergy and Clinical Immunology 123: 376–384.PubMedCrossRef Saunders, R., S. Siddiqui, D. Kaur, C. Doe, A. Sutcliffe, F. Hollins, P. Bradding, A. Wardlaw, and C.E. Brightling. 2009. Fibrocyte localization to the airway smooth muscle is a feature of asthma. The Journal of Allergy and Clinical Immunology 123: 376–384.PubMedCrossRef
34.
go back to reference Hoshino, M., M. Takahashi, and N. Aoike. 2001. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. The Journal of Allergy and Clinical Immunology 107: 295–301.PubMedCrossRef Hoshino, M., M. Takahashi, and N. Aoike. 2001. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. The Journal of Allergy and Clinical Immunology 107: 295–301.PubMedCrossRef
35.
go back to reference Takahashi, H., M. Numasaki, M.T. Lotze, and H. Sasaki. 2005. Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells. Immunology Letters 98: 189–193.PubMedCrossRef Takahashi, H., M. Numasaki, M.T. Lotze, and H. Sasaki. 2005. Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells. Immunology Letters 98: 189–193.PubMedCrossRef
36.
go back to reference Wang, Y.H., and M. Wills-Karp. 2011. The potential role of interleukin-17 in severe asthma. Current Allergy and Asthma Reports 11: 388–394.PubMedCrossRef Wang, Y.H., and M. Wills-Karp. 2011. The potential role of interleukin-17 in severe asthma. Current Allergy and Asthma Reports 11: 388–394.PubMedCrossRef
37.
go back to reference McKinley, L., J.F. Alcorn, A. Peterson, R.B. Dupont, S. Kapadia, A. Logar, A. Henry, C.G. Irvin, J.D. Piganelli, A. Ray, and J.K. Kolls. 2008. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. The Journal of Immunology 181: 4089–4097.PubMed McKinley, L., J.F. Alcorn, A. Peterson, R.B. Dupont, S. Kapadia, A. Logar, A. Henry, C.G. Irvin, J.D. Piganelli, A. Ray, and J.K. Kolls. 2008. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. The Journal of Immunology 181: 4089–4097.PubMed
38.
go back to reference Sakai, N., K. Furuichi, Y. Shinozaki, H. Yamauchi, T. Toyama, S. Kitajima, T. Okumura, S. Kokubo, M. Kobayashi, K. Takasawa, S. Takeda, M. Yoshimura, S. Kaneko, and T. Wada. 2010. Fibrocytes are involved in the pathogenesis of human chronic kidney disease. Human Pathology 41: 672–678.PubMedCrossRef Sakai, N., K. Furuichi, Y. Shinozaki, H. Yamauchi, T. Toyama, S. Kitajima, T. Okumura, S. Kokubo, M. Kobayashi, K. Takasawa, S. Takeda, M. Yoshimura, S. Kaneko, and T. Wada. 2010. Fibrocytes are involved in the pathogenesis of human chronic kidney disease. Human Pathology 41: 672–678.PubMedCrossRef
Metadata
Title
IL-17A/F Modulates Fibrocyte Functions in Cooperation with CD40-Mediated Signaling
Authors
Hisako Hayashi
Akiko Kawakita
Shintaro Okazaki
Motoko Yasutomi
Hiroki Murai
Yusei Ohshima
Publication date
01-08-2013
Publisher
Springer US
Published in
Inflammation / Issue 4/2013
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9609-z

Other articles of this Issue 4/2013

Inflammation 4/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.